title: Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression.
authors.affiliation: Department of Nephrology, Hospital de Bellvitge Princeps d'Espanya, University of Barcelona.
authors.forename: A M
authors.initials: AM
authors.lastname: Castelao
authors.forename: M J
authors.initials: MJ
authors.lastname: Barberá
authors.forename: A
authors.initials: A
authors.lastname: Blanco
authors.forename: C
authors.initials: C
authors.lastname: Fiol
authors.forename: J M
authors.initials: JM
authors.lastname: Griñó
authors.forename: J
authors.initials: J
authors.lastname: Bover
authors.forename: S
authors.initials: S
authors.lastname: GilVernet
authors.forename: E
authors.initials: E
authors.lastname: Andrés
authors.forename: D
authors.initials: D
authors.lastname: Serón
authors.forename: M J
authors.initials: MJ
authors.lastname: Castiñeiras
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001053:Apolipoproteins / Q000097:blood*; D002784:Cholesterol / Q000097:blood*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D011507:Proteinuria; D012044:Regression Analysis; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
chemical_list: D000961:Antilymphocyte Serum; D001053:Apolipoproteins; D008074:Lipoproteins; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D011241:Prednisone